Histology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in Adults and Children

被引:201
|
作者
Kleiner, David E. [1 ]
Makhlouf, Hala R. [2 ,3 ]
机构
[1] NCI, Pathol Lab, Ctr Canc Res, Bldg 10,Room 2S235,MSC 1500,10 Ctr Dr, Bethesda, MD 20892 USA
[2] NCI, Canc Diag Program, Pathol Invest & Resources Branch, Div Canc Treatment & Diag, 9609 Med Ctr Dr,Room 4W438, Bethesda, MD 20892 USA
[3] Ain Shams Univ, Fac Med, Dept Pathol, 38 Al Abbassyah, Cairo 11566, Greater Cairo, Egypt
关键词
Steatohepatitis; Liver biopsy; Steatosis; Histology; Scoring; Staging; PLACEBO-CONTROLLED-TRIAL; RANDOMIZED CONTROLLED-TRIAL; CLINICAL-RESEARCH NETWORK; CRYPTOGENIC CIRRHOSIS; NATURAL-HISTORY; UNITED-STATES; FOLLOW-UP; VITAMIN-E; URSODEOXYCHOLIC ACID; RISK-FACTORS;
D O I
10.1016/j.cld.2015.10.011
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Nonalcoholic fatty liver disease (NAFLD) is the liver disease associated with obesity, diabetes, and the metabolic syndrome. Although steatosis is a key histologic feature, liver biopsies of patients with NAFLD can show a wide range of findings. Nonalcoholic steatohepatitis (NASH) is a progressive subtype of NAFLD first defined by analogy to alcoholic hepatitis. Young children may have an alternate pattern of progressive NAFLD characterized by a zone 1 distribution of steatosis, inflammation, and fibrosis. Several grading and staging systems exist, but all require adequate biopsies. Although NASH generally shows fibrosis progression over time, some patients show regression of disease.
引用
收藏
页码:293 / +
页数:21
相关论文
共 50 条
  • [41] Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
    Younossi, Zobair M.
    Henry, Linda
    Bush, Haley
    Mishra, Alita
    CLINICS IN LIVER DISEASE, 2018, 22 (01) : 1 - +
  • [42] The spectrum of nonalcoholic fatty liver disease: From steatosis to nonalcoholic steatohepatitis
    Saadeh, S
    Younossi, ZM
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2000, 67 (02) : 96 - +
  • [43] Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH)
    Duarte, Sebastiao M. B.
    Stefano, Jose Tadeu
    Oliveira, Claudia P.
    ANNALS OF HEPATOLOGY, 2019, 18 (03) : 416 - 421
  • [44] Predictors of steatohepatitis in nonalcoholic fatty liver disease
    Ozturk, Kadir
    Demirci, Hakan
    Kurt, Omer
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 28 (05) : 606 - 607
  • [45] CARDIOVASCULAR RISK FACTORS IN NONALCOHOLIC FATTY LIVER DISEASE/NONALCOHOLIC STEATOHEPATITIS
    Ivanova, R.
    Gospodinova, M.
    Petrova, J.
    Alexiev, A.
    Denchev, S.
    Mateva, L.
    ATHEROSCLEROSIS, 2014, 235 (02) : E240 - E240
  • [46] Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
    Takahashi, Yoshihisa
    Sugimoto, Keiichiro
    Inui, Hiroshi
    Fukusato, Toshio
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (13) : 3777 - 3785
  • [47] The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    Chow, Monica D.
    Lee, Yi-Horng
    Guo, Grace L.
    MOLECULAR ASPECTS OF MEDICINE, 2017, 56 : 34 - 44
  • [49] Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: The Disease Burden Grows Foreword
    Buchman, Alan L.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2020, 49 (01) : XI - XII
  • [50] Is Nonalcoholic Fatty Liver Disease in Children the Same Disease as in Adults?
    Hsu, Evelyn
    Murray, Karen
    CLINICS IN LIVER DISEASE, 2012, 16 (03) : 587 - +